Literature DB >> 35580445

MR elastography as a biomarker for prediction of early and late recurrence in HBV-related hepatocellular carcinoma patients before hepatectomy.

Lina Zhang1, Jingbiao Chen1, Hang Jiang1, Dailin Rong1, Ning Guo1, Hao Yang2, Jie Zhu1, Bing Hu1, Bingjun He1, Meng Yin3, Sudhakar K Venkatesh3, Richard L Ehman3, Jin Wang4.   

Abstract

PURPOSE: To investigate the diagnostic performance of preoperative MR elastography (MRE) in predicting early recurrence (ER) and late recurrence (LR) of HCC after hepatectomy.
METHOD: In total, 180 patients (median age, 52 years; interquartile range, 41-50 years; 161 men) who underwent conventional MRI and MRE before hepatectomy between December 2014 and April 2020 were retrospectively recruited. A preoperative clinic-radiologic model and a combined postoperative clinic-pathologic and radiologic model were built using quantitatively MRE-derived stiffnesses, and image features to predict tumor ER and LR after hepatectomy. The Cox proportional hazards model and ROC analyses were used to identify the value of parameters to predict ER and LR.
RESULTS: Seventy-three (40.5%) and 16 (8.9%) developed ER and LR after hepatectomy, respectively. For prediction of ER, the preoperative model integrated higher tumor stiffness (TS) (hazard ratio [HR],1.142; p < 0.001) with AFP ≥ 400 ng/mL (HR,1.761; p = 0.022), multifocal tumors (HR,3.229; p < 0.001) and lower ADC (HR,0.998; p = 0.017) variables; and the postoperative model incorporated higher TS, microvascular invasion, multifocal tumors, Child-Pugh class and ADC predictors. The two models provided comparable predictive performance (pre- 0.812 vs. post- 0.834, p = 0.283). Moreover, TS alone had a high sensitivity (90.4%) for predicting ER. Liver stiffness (LS) (HR, 1.757; p < 0.001) was the only independent predictor for LR in multivariate analysis in both the pre- and postoperative models with high specificity (90.0%), and its AUC with an optimal cut-off of 3.62 kPa was 0.860.
CONCLUSIONS: Quantitative MRE-based stiffness is a useful biomarker for preoperative prediction of ER and LR of HCC.
Copyright © 2022. Published by Elsevier B.V.

Entities:  

Keywords:  Elasticity imaging techniques; Hepatocellular carcinoma; Magnetic resonance; Prognosis; Recurrence

Mesh:

Substances:

Year:  2022        PMID: 35580445      PMCID: PMC9535659          DOI: 10.1016/j.ejrad.2022.110340

Source DB:  PubMed          Journal:  Eur J Radiol        ISSN: 0720-048X            Impact factor:   4.531


  38 in total

1.  Diagnostic accuracy of 3D magnetic resonance elastography for assessing histologic grade of hepatocellular carcinoma: comparison of three methods for positioning region of interest.

Authors:  Weimin Liu; Dailin Rong; Jie Zhu; Yuanqiang Xiao; Linqi Zhang; Ying Deng; Jun Chen; Meng Yin; Sudhakar K Venkatesh; Richard L Ehman; Jin Wang
Journal:  Abdom Radiol (NY)       Date:  2021-06-03

2.  Radiomics on Gadoxetic Acid-Enhanced Magnetic Resonance Imaging for Prediction of Postoperative Early and Late Recurrence of Single Hepatocellular Carcinoma.

Authors:  Sungwon Kim; Jaeseung Shin; Do-Young Kim; Gi Hong Choi; Myeong-Jin Kim; Jin-Young Choi
Journal:  Clin Cancer Res       Date:  2019-02-26       Impact factor: 12.531

3.  AASLD guidelines for the treatment of hepatocellular carcinoma.

Authors:  Julie K Heimbach; Laura M Kulik; Richard S Finn; Claude B Sirlin; Michael M Abecassis; Lewis R Roberts; Andrew X Zhu; M Hassan Murad; Jorge A Marrero
Journal:  Hepatology       Date:  2018-01       Impact factor: 17.425

4.  Predictive value of tumor markers in patients with recurrent hepatocellular carcinoma in different vascular invasion pattern.

Authors:  Feng Gao; Heng-Kai Zhu; Yang-Bo Zhu; Qiao-Nan Shan; Qi Ling; Xu-Yong Wei; Hai-Yang Xie; Lin Zhou; Xiao Xu; Shu-Sen Zheng
Journal:  Hepatobiliary Pancreat Dis Int       Date:  2016-08

5.  3D MR Elastography of Hepatocellular Carcinomas as a Potential Biomarker for Predicting Tumor Recurrence.

Authors:  Jin Wang; Qungang Shan; Yong Liu; Hao Yang; Sichi Kuang; Bingjun He; Yao Zhang; Jingbiao Chen; Tianhui Zhang; Kevin J Glaser; Cairong Zhu; Jun Chen; Meng Yin; Sudhakar K Venkatesh; Richard L Ehman
Journal:  J Magn Reson Imaging       Date:  2018-09-08       Impact factor: 4.813

Review 6.  EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma.

Authors: 
Journal:  J Hepatol       Date:  2018-04-05       Impact factor: 25.083

7.  [Hepatocellular carcinoma: new provisions of the WHO classification, 5th edition, 2019].

Authors:  E M Nepomnyashchaya; A V Shaposhnikov; E A Yurieva
Journal:  Arkh Patol       Date:  2020

8.  Tumor Stiffness Measurements on MR Elastography for Single Nodular Hepatocellular Carcinomas Can Predict Tumor Recurrence After Hepatic Resection.

Authors:  Sae-Jin Park; Jeong Hee Yoon; Dong Ho Lee; Woo Hyeon Lim; Jeong Min Lee
Journal:  J Magn Reson Imaging       Date:  2020-09-11       Impact factor: 4.813

Review 9.  Non-invasive evaluation of liver fibrosis using transient elastography.

Authors:  Laurent Castera; Xavier Forns; Alfredo Alberti
Journal:  J Hepatol       Date:  2008-02-26       Impact factor: 25.083

10.  Management of hepatocellular carcinoma: an update.

Authors:  Jordi Bruix; Morris Sherman
Journal:  Hepatology       Date:  2011-03       Impact factor: 17.425

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.